Placebo is non-inferior to postoperative antimicrobial treatment in uncomplicated canine pyometra - a double-blinded randomized controlled trial
Abstract
Postoperative antimicrobial therapy is frequently administered after surgical treatment for pyometra in dogs, despite limited evidence supporting its necessity in uncomplicated cases. Antimicrobial resistance concerns call for re-evaluation of such practices. This randomized, double-blinded, placebo-controlled, non-inferiority clinical trial was conducted on client-owned dogs at the Veterinary Teaching Hospital of the University of Helsinki. All dogs received perioperative sulfadoxine-trimethoprim prophylaxis and were then randomized to receive either placebo or a five-day course of oral sulfadiazine-trimethoprim as active control. The primary outcome was the incidence of surgical site infections (SSI) within 30 days; the secondary outcome was the incidence of clinical urinary tract infections (UTI) within 12 days. The non-inferiority margins were set at 7% (SSI) and 15% (UTI). Infection outcomes were assessed in both the intention-to-treat (ITT) and per-protocol populations (PP). A total of 152 dogs were included. In the ITT population, SSI incidence was 2.7% in the placebo group and 7.8% in the sulfadiazine-trimethoprim group, with an absolute difference of -5.1% (CI95%: -13.6% to 2.8%). UTI incidence was 0% in the placebo group and 3.9% in the sulfadiazine-trimethoprim group (difference -7.7%, CI95%: -24.1% to 8.2%). Results in the PP were similar. All findings supported the non-inferiority of placebo. A single perioperative dose of sulfadoxine-trimethoprim appears…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.